Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04281368
Other study ID # IUFD
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date January 1, 2020

Study information

Verified date April 2020
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

All stillbirths in Stockholm during 2017 were analysed according to the primary outcomes which were preventable/non-preventable deaths and the level of delay. The secondary outcomes were: causes of death, standard of care pre and post stillbirth and if a summary of the possible causes of death was made as well as the planning of supervision of the next pregnancy.


Description:

This is a retrospective cohort study. A multidisciplinary team consisting of three obstetricians, one midwife and one neonatologist was assembled. The team represented the largest hospitals in the region-Karolinska University Hospital and Stockholm Soderl Hospital. Each team member in the audit group had access to all the medical patient charts from the hospitals and also the majority of the charts from the antenatal care clinics (ANC). Each team member independently assessed each case regarding causes of death, preventable/non-preventable deaths, the level of delay if there was any and the standard of healthcare provided to the patients with stillbirth, the postmortem examination of infant and mother and if there were any recommendations given for the next pregnancy. Multiple meetings were organized for discussing the results of the individual assessment of each case. To enable an ethical discussion every member of the audit group signed a confidentiality form and all cases were assessed by comparison with local guidelines in praxis.


Recruitment information / eligibility

Status Completed
Enrollment 79
Est. completion date January 1, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- All stillbirths in Stockholm 2017

Exclusion Criteria:

- Missed abortion

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Analysis of IUFD
Each team member in the audit group had access to all the medical patient charts from the hospitals and also the majority of the charts from the antenatal care clinics (ANC). Each team member independently assessed each case regarding causes of death, preventable/non-preventable deaths, the level of delay if there was any and the standard of healthcare provided to the patients with stillbirth, the postmortem examination of infant and mother and if there were any recommendations given for the next pregnancy

Locations

Country Name City State
Sweden Eva Wiberg-Itzel Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary The rate of preventable/non-preventable deaths and the level of delay to analyze preventable/non-preventable deaths and the level of delay 2017
Secondary The frequency of different causes of death To analyze the different causes of death 2017